New balloon treatment may be safer for heart patients prone to bleeding
NCT ID NCT05221931
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for blocked heart arteries in people who are at high risk of bleeding. One treatment uses a drug-coated balloon (DCB) and the other a drug-eluting stent (DES). The goal is to see if the balloon works just as well as the stent while possibly causing less bleeding. Over 1,300 participants are being followed to track heart-related events and bleeding complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- drug-coated balloon (DCB) or drug-eluting stent (DES)
- What this could lead to
- If successful, this could offer a safer treatment option for people with coronary artery disease who are at high risk of bleeding, potentially reducing complications like bleeding and heart attacks.
- What could go wrong
- This is a noninferiority trial, meaning it aims to show DCB is not worse than DES, not necessarily better. Results may not apply to all patients, and long-term outcomes are still unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chonnam National University Hospital
Gwangju, South Korea
-
Chung-Ang University Gwangmyeong Hospital
Gwangmyeong, South Korea
-
Chungbuk National University
Cheongju-si, South Korea
-
Ewha Womans University College of Medicine
Seoul, South Korea
-
Gangneung Asan Hospital, University of Ulsan College of Medicine
Gangneung, South Korea
-
Gyeongsang National University Hospital
Jinju, South Korea
-
Inha University Hospital
Incheon, South Korea
-
Kangbuk Samsung Hospital
Seoul, South Korea
-
Keimyung University Dongsan Hospital
Daegu, South Korea
-
Korea University Ansan Hospital
Ansan, South Korea
-
Korea University Kuro Hospital
Seoul, South Korea
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Boramae Medical Center
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, South Korea
-
Seoul St. Mary's Hospital, The Catholic University of Korea
Seoul, South Korea
-
The Catholic University of Korea, Uijeongbu St. Mary's Hospital
Uijeongbu-si, South Korea
-
Wonju Severance Christian Hospital
Wŏnju, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Step by step: a coaching program aims to keep heart patients moving after rehab
- Heart bypass upgrade: which Artery-Harvesting technique works best?
- Can a noble gas protect the heart during bypass surgery?
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack